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Background: Pdx1 interacts with the 
methyltransferase Set7/9 to transactivate β cell 
genes.   
Result:  Methylation of Pdx1 residue K131 by 
Set7/9 augments Pdx1 activity. 
Conclusion: The ability of Pdx1 to regulate genes 
in β cells is partially dependent upon its 
methylation by Set7/9.  
Significance: This study reveals a previously 
unappreciated role for Lys methylation in the 
maintenance of Pdx1 activity and β cell function. 
 
SUMMARY 
The transcription factor Pdx1 is crucial 
to islet β cell function, and regulates target 
genes in part through interaction with co-
regulatory factors. Set7/9 is a Lys 
methyltransferase that interacts with Pdx1.  
Here, we tested the hypothesis that Lys 
methylation of Pdx1 by Set7/9 augments Pdx1 
transcriptional activity.  Using mass 
spectrometry and mutational analysis of 
purified proteins, we found that Set7/9 
methylates N-terminal residues K123 and K131 
of Pdx1.  Methylation of these residues 
occurred only in the context of intact, full-
length Pdx1, suggesting a specific requirement 
of secondary and/or tertiary structural 
elements for catalysis by Set7/9. 
Immunoprecipitation assays and mass 
spectrometric analysis using β cells verified Lys 
methylation of endogenous Pdx1. Cell-based 
luciferase reporter assays using wild-type and 
mutant transgenes revealed a requirement of 
Pdx1 residue K131, but not K123, for 
transcriptional augmentation by Set7/9. K131 
was not required for high affinity interactions 
with DNA in vitro, suggesting that its 
methylation likely enhances post-DNA binding 
events. To define the role of Set7/9 in β cell 
function, we generated mutant mice in which 
the gene encoding Set7/9 was conditionally 
deleted in β cells (Set∆β). Set∆β mice exhibited 
glucose intolerance similar to Pdx1-deficient 
mice, and their isolated islets showed impaired 
glucose-stimulated insulin secretion with 
reductions in expression of Pdx1 target genes. 
Our results suggest a previously unappreciated 
role for Set7/9-mediated methylation in the 
maintenance of Pdx1 activity and β cell 
function. 
 
INTRODUCTION 
Deficiency of insulin secretion underlies 
the transition from normoglycemia to 
hyperglycemia in both type 1 and type 2 diabetes 
(1, 2). Circulating insulin arises almost exclusively 
from islet β cells in the pancreas, but our 
understanding of the molecular mechanisms 
governing β cell function in health and disease 
remains incomplete.  A key protein that is 
essential for β cell function is the homeobox 
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transcription factor Pdx1.  During mammalian 
development, Pdx1 is essential for pancreas 
organogenesis  (3–5).  In the adult pancreas, Pdx1 
is restricted primarily to β cells and is responsible 
for the regulation of genes that are essential to β 
cell function, proliferation, and survival (6, 7).  In 
this context, elucidating the molecular 
mechanisms of Pdx1 action will be crucial in 
future attempts to restore β cell function in the 
setting of diabetes. 
The interaction of Pdx1 with other 
transcription factors and cofactors appears to be 
important in modulating Pdx1 activity (positively 
or negatively) at a given target gene. For example, 
the formation of a transcriptional complex 
between Pdx1 and the basic helix-loop-helix factor 
NeuroD1 in β cells results in the formation of a 
complex with the gene encoding preproinsulin 
(Ins1/2) that permits synergistic activation of 
transcription (8, 9).  By contrast, interaction of 
Pdx1 with PCIF1 results in degradation of Pdx1 
protein by the proteasome and consequent 
reduction in Pdx1 activity (10).  Interactions such 
as these suggest a model whereby various aspects 
of Pdx1 activity, including DNA binding affinity, 
protein stability, and recruitment of basal 
transcriptional machinery are modulated to 
achieve homeostatic function of the β cell. 
Our laboratory has previously reported 
that the lysine methyltransferase Set7/9 interacts 
with Pdx1 to promote transactivation of an Ins1/2 
mini-enhancer (11) that contains the classical Pdx1 
binding sequence (5’-TAAT-3’) present in 
elements A3 and A4. Augmentation of 
transcriptional activity was correlated with an 
increase in Lys4 methylation of histone 3 (H3) and 
the conversion of the initiating isoform of RNA 
polymerase II to its elongating isoform.  In recent 
years, several reports suggested that the 
methyltransferase activity of Set7/9 is not 
restricted only to Lys residues on histones, but 
includes Lys residues of other proteins, such as 
p53, p65, and estrogen receptor-α, among others 
(12–15).  These varied methylation events were 
shown to alter the activity or half-life of these 
proteins, emphasizing that Lys methylation 
(similar to Ser/Thr phosphorylation or Lys 
acetylation) modulates transcription factor 
function (16, 17).   
In light of these new perspectives on Lys 
methylation and Set7/9 action, we asked if the 
interactions between Set7/9 and Pdx1 might affect 
Pdx1 activity independently of effects on histones. 
In this study, our findings reveal a heretofore 
unappreciated role for Lys-specific methylation of 
Pdx1 by Set7/9 in the maintenance of normal β 
cell function.   
 
MATERIALS AND METHODS 
Cells, animals, and assays—NIH3T3, 
HEK293, MIN6 cells, and INS-1 cells were 
cultured as described previously (11, 18–20).  All 
animal studies were reviewed and approved by the 
Indiana University Institutional Animal Care and 
Use Committee.  Setd7Loxp/+ mice, in which Cre 
recombinase recognition sequences (Loxp) flank 
exon 2, were generated by subcontract to 
Ingenious Targeting Labs.  The neomycin 
selection cassette was removed by crossing 
Setd7Loxp/+ mice to the FLPR strain.  Mice were 
backcrossed onto the C57BL/6 background for 10 
generations.  MIP1-CreERT mice on the C57BL/6 
background were kindly provided by Dr. L. 
Philipson (21).  For induction of Cre-mediated 
recombination, mice were orally gavaged with 
tamoxifen dissolved in peanut oil (mixed for 1 
hour at 550C) at a dose of 5 mg/day/mouse.  
Intraperitoneal glucose tolerance tests using 2g/kg 
body weight glucose proceeded as described 
previously (22).  Islets were isolated from 
collagenase-perfused pancreata as described 
previously (23).  Static glucose-stimulated insulin 
secretion assays using islets were performed as 
previously described (22), and insulin released 
into the medium was normalized to total islet 
insulin content.  Insulin was measured using a 
mouse insulin enzyme-linked immunosorbent 
assay (ELISA) kit (Alpco Diagnostics). 
Recombinant plasmids, mutagenesis, and 
PCR—Plasmids were generated using standard 
recombinant techniques. PCR-generated constructs 
were verified by automated sequencing. 
Recombinant protein was expressed using the E. 
coli expression vectors pET21d or pET15b and 
purified as described previously (24).  
Recombinant Set7/9 protein was purchased from 
Prospec.  Point mutations were generated using the 
Quick Change® site directed mutagenesis kit 
(Agilent). The following primers were used to 
make the respective point mutants:  K123R: 5’-
CAGCTGCCTTTCCCATGGATGAGGTCGACC
AAAGCTCAC-3' and 5'-
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GTGAGCTTTGGTCGACCTCATCCATGGGAA
AGGCAGCTG-3'. K126R: 5'-
TCCCATGGATGAAGTCTACCAGAGCTCAC
GCGT-3' and 5'-
ACGCGTGAGCTCTGGTAGACTTCATCCATG
GGA-3'.  K131R: 5'-
CCAAAGCTCACGCGTGGAGAGGCCAGTGG
-3' and 5'-
CCACTGGCCTCTCCACGCGTGAGCTTTGG-
3'.  CMV promoter-driven vectors (pBAT12) were 
used to express wild-type and mutant Pdx1 in 
HEK293 and NIH3T3 cells, as described 
previously (9). The CMV promoter-driven vector 
used to drive Setd7 was described previously (25). 
Methods primers for SYBR Green-based real-time 
RT-PCR was described previously (26). 
Antibodies and Demethylase Inhibitor—
Pdx1 antibody was obtained from Millipore (#07-
696). Set7/9 antibody was obtained from Cell 
Signaling (#2813). Monoclonal Flag M2 antibody 
was obtained from Sigma-Aldrich (#F1804).  
Anti-Pdx1(K131-methyl) antibody was generated 
in rabbits by contract to 21st Century Biochemicals 
using the following synthetic peptides:  methylated 
peptide 1:  C-Ahx-TKAHAW[K-Me1]GQWAG-
amide, and methylated peptide 2:  Ac-AHAW[K-
Me1]GQWAGGA-Ahx-KKC-amide. Gapdh 
antibody was obtained from Ambion (#AM4300).  
Fluorophore-labeled secondary antibodies IRDye 
700 and IRDye 800 were obtained from Licor 
Biosciences.  The demethylase inhibitor BP-107-7 
was synthesized using a previously described 
synthetic route (27, 28).- 
Methylation Assays In Vitro—Purified 
Pdx1 protein (150 nM – 1.2 µM) and Set7/9 
protein (200 nM) were incubated at 30 °C for 3 
hours in a reaction buffer containing 50mM Tris 
(pH 8.5), 4mM DTT, 5mM MgCl2 , 0.05mg/ml 
BSA, 1 µM 3H-AdoMet, and 50 µM AdoMet in 20 
µl volume. The reaction was stopped by the 
addition of 6X SDS gel loading buffer. Analysis 
by polyacrylamide gel electrophoresis proceeded 
as described previously (11).  
Co-immunoprecipitation assays—
Immunoprecipitations from whole cell lysates 
using Protein A or Protein G Dynabeads (Life 
Technologies) proceeded as described previously 
(11).  Immunoprecipitations involving anti-HA 
antibody, which was performed using the HA-tag 
IP kit (Pierce).  Chromatin immunoprecipitation 
(ChIP) assays was performed using the Active 
Motif ChIP-IT® Express Enzymatic kit (#53009), 
per manufacturer’s protocol. 
Immunoblot Analysis—Samples were 
resolved on 10% polyacrylamide gels and were 
then transferred onto a PVDF membrane 
(Millipore).  Membranes were exposed to primary 
antibody, overnight at 4 °C and then processed as 
described previously (29). 
Transient transfections and luciferase 
reporter assays—Cells were transfected using 
Metafectene Pro (Biontex) according to 
manufacturer’s instructions in 6 well tissue culture 
plates.  After 48 hours, whole cell extracts were 
used to assess luciferase activity using a 
commercially available luciferase assay kit 
(Promega). 
Generation and Purification of tandem 
affinity purification tag (TAP)-Pdx1 from MIN6 
Cells—The full-length mouse Pdx1 cDNA 
sequence was inserted in-frame into pNTAP-C 
vector (Stratagene), generating TAP-Pdx1 with the 
TAP tag fused to the N-terminus of Pdx1.  The 
TAP-Pdx1 sequence was then subcloned into the 
pAdTrack-CMV shuttle vector, which was used to 
generate recombinant adenoviruses expressing N-
terminal TAP-tagged full-length Pdx1 as described 
previously (30).  MIN6 cells were infected with 
the purified TAP-Pdx1 or control GFP adenovirus 
as previously described (30, 31) and lysed after 48 
hours later.  TAP Pdx1 was purified using the 
InterPlay TAP purification system (Stratagene) 
and subjected to mass spectrometry. 
Electrophoretic mobility shift assays 
(EMSAs)8—The Ins E-A probe 5’-
GATCCTTCATCAGGCCATCTGGCCCCTTGT
TAATAATCTAATTACCCTAGGTCTAA-3’ 
was labeled with γ32P-ATP using T4 
polynucleotide kinase, then duplexed with 
unlabeled complementary strand (5’-
GATCTTAGACCTAGGGTAATTAGATTATTA
ACAAGGGGCCAGATGGCCTGATGAAG-3’). 
Nuclear extracts from transfected NIH3T3 cells 
were isolated as previously described (19), and 
around 2 µg of total nuclear protein was used in 
each EMSA reaction with labeled Ins E-A probe. 
Competition EMSAs were performed using 
unlabeled Ins E-A probe. EMSA reactions 
proceeded at room temperature for 15 min.  
EMSA buffer and electrophoresis protocol was 
previously described (32). The gel was visualized 
and competition EMSAs were quantitated using 
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using a phosphorimager (Molecular Dynamics). 
Competition EMSAs were modeled based on 
single phase exponential dissociation using the 
non-linear least squares fit algorithm in Prism 5.0 
software (GraphPad), and apparent dissociation 
constants were determined, as previously 
described (24).   
Mass spectrometry analysis—Samples 
(proteins from in vitro experiments and from 
MIN6 cells) were first denatured with 8M urea, 
then reduced with 10 mM DTT in 10 mM 
ammonium bicarbonate and alkylated with 55 mM 
iodoacetamide (prepared in 10 mM ammonium 
bicarbonate), and then digested with trypsin, 
incubated overnight at 37°C.  The samples in vitro 
were analyzed using Thermo-Fisher Scientific 
LTQ Orbitrap Velos Pro and Surveyor HPLC. 
Tryptic peptides were injected onto the C18 
column.  Peptides were eluted with a linear 
gradient from 3 to 40% acetonitrile (in water with 
0.1% FA) developed over 90 minutes at room 
temperature, at a flow rate of 60ul/min, and 
effluent was electro-sprayed into the LTQ mass 
spectrometer.  Blanks were run prior to the sample 
run to make sure there was no significant signal 
from solvents or the column.  The TSKgel 
columns (ODS-100 V, 3 μm, 1.0 mm × 50 mm) 
were used for the Surveyor HPLC system. The 
trypsin digested Pdx1 immunoprecipitants from 
MIN6 cells were pressure loaded onto a 12 cm 
multidimensional protein identification technology 
(MudPIT) column as previously described (33). 
Peptides were analyzed by MS/MS on an LTQ XL 
mass spectrometer following elution during a 10-
step MudPIT run. Protein database searches were 
performed using Sequest® algorithms within 
Proteome Discoverer (Thermo) against appropriate 
FASTA sequence databases obtained from 
UniProt. Database searches included dynamic 
modification analysis for mono-, di-, and tri-
methylated Lys residues, and Met residue 
oxidation. 
Statistical analysis—All data are presented 
as the mean ± SEM.  One-way ANOVA (followed 
by a Dunnett’s post test) was used for comparisons 
in which two or more conditions were compared, 
and a two-tailed Student’s t test was performed 
when two conditions were compared.  Prism 5.0 
software (GraphPad) was used for all statistical 
analyses.  Statistical significance was defined as 
P<0.05. 
 
RESULTS 
Pdx1 is methylated by Set7/9 in vitro at positions 
K123 and K131 
Recent evidence suggesting that Set7/9 
methylates non-histone proteins led us to 
investigate first if the interaction between Set7/9 
and Pdx1 leads to Lys methylation of Pdx1. We 
performed methylation reactions in vitro using 
purified Pdx1 and Set7/9 proteins and 3H-S-
adenosyl methionine (3H-AdoMet).  Incorporation 
of 3H-methyl group into Pdx1 in this reaction is 
evidence of protein methylation (11).  As shown in 
Fig. 1A, 3H-methyl was incorporated into Pdx1 in 
a concentration-dependent manner, and only in the 
presence of Set7/9.  By contrast, no methylation of 
bovine serum albumin is observed in the same 
reaction, suggesting that the methylation is 
specific for Pdx1 (Fig. 1A).   
Prior studies suggest that Lys residues in a 
broad range of sequence contexts can serve as 
substrates for Set7/9 (34),  Within Pdx1, Lys 
residues occur in both the N-terminal 
transactivation domain (residues K15, K123, 
K126, K131) and the DNA binding homeodomain 
(residues K147, K163, K191, K200, K202, K203, 
K207, K208).  To narrow the possible Lys 
residues that may be methylated by Set7/9, we 
next performed methylation assays using different 
truncated mutants of Pdx1, as shown in Fig. 1B.  
Surprisingly, none of the truncated mutants were 
methylated by Set7/9 in vitro, suggesting that 
methylation of Pdx1 required the structural context 
of the full-length protein.   
To identify the methylated Lys residue(s) 
in the full-length protein, we next performed mass 
spectrometry of methylated full-length Pdx1. 
Broad coverage of the peptides confirmed the 
mono-methylation of Pdx1 at two Lys residues in 
the N terminal region of the protein—residues 
K123 and K131 (Fig. 2A and B).  Data from the 
mass spectrometric analysis was verified using 
mutated Pdx1 proteins, in which residues K123, 
K126, and K131 in the N-terminal domain were 
mutated to Arg (K123R, K126R, and K131R).  As 
shown in Fig. 1C, reductions in methylation of 
Pdx1 clearly occurred in K123R mutant, but no 
statistically significant reduction was seen in the 
K131R mutant.  Little residual methylation was 
observed in the K123R+K131R double mutant.  
Together, these data suggest that residue K123 
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appears to be the kinetically preferred site for 
methylation by Set7/9 in vitro, with evidence of 
lesser methylation occurring at K131. 
 
K131 of Pdx1 is required for transcriptional 
augmentation by Set7/9 
 In prior studies, we showed that Set7/9 
augments the transcriptional activity of Pdx1 in 
the context of a Pdx1 reporter (containing 5 
tandem Pdx1 binding sites); this result was 
previously ascribed to Set7/9-mediated 
methylation of H3 (residue K4) at this reporter 
(11).  Based on our results in Fig. 1, we considered 
the possibility that this transcriptional 
augmentation by Set7/9 might instead be a result 
of Pdx1 Lys methylation.  To test this possibility, 
we performed reporter gene activity assays using 
wild-type and mutated Pdx1 in the mouse-derived 
cell line NIH3T3, which is devoid of endogenous 
Pdx1.  As shown in Fig. 3A, when a cDNA 
encoding wild-type Pdx1 is co-transfected into 
NIH3T3 cells with a Pdx1 reporter plasmid 
containing tandem copies of a Pdx1 binding 
sequence (derived from the rat Ins1 E2/A4/A3 
promoter element) driving luciferase (9), 
approximately 12-fold activation of luciferase 
activity is observed.  No activation is observed, 
however, upon co-transfection of the reporter with 
a cDNA encoding Set7/9 alone (Fig. 3A).  When 
cDNAs encoding both wild-type Pdx1 and Set7/9 
are co-transfected, a more-than-additive 18-fold 
activation of the reporter is observed.  Whereas 
mutation of residue K123 to Arg (K123R) had no 
effect on reporter gene transactivation, mutation of 
K131 to Arg (K131R) or the double mutation 
K123R+K131R resulted in loss of transcriptional 
augmentation by Set7/9 (Fig. 3A).  These effects 
were specific for the Pdx1 reporter, since no 
significant effects were observed on the control 
Gal4 reporter (which contains 5 tandem copies of 
the yeast Gal4 recognition sequence) (Fig. 3B).  
Additionally, the effects of the K131R mutation 
was not caused by changes in Pdx1 levels, since 
all transfected Pdx1 mutants showed similar 
intensity on immunoblot analysis (Fig. 3C).  These 
results suggest that although both K123 and K131 
appear to be targets for methylation by Set7/9 in 
vitro (with the former being preferred), only K131 
appears to be required for the transcriptional 
augmentation of reporter activity in cells.    
 Lys methylation has been shown to affect 
multiple aspects of transcription factor activity, 
including protein half-life and DNA binding 
affinity ((17, 35)).  We suspected that effects of 
the K131R mutation on Pdx1 half-life were 
negligible, since proteins levels of the transfected 
proteins were identical for wild-type and mutants 
(Fig. 3C). To test if loss of transcriptional 
augmentation activity between Pdx1 K131R and 
Set7/9 was due to decreased interaction between 
the two proteins, a co-immunoprecipitation assay 
for Set7/9 and Pdx1 using NIH3T3 cells 
transfected with wild-type or mutant Pdx1 and 
Set7/9 was performed (Fig 3D). Neither the 
K131R mutant nor the K123+K131R double  
mutant exhibited any differences in their 
interaction with Set7/9, suggesting that interaction 
between Pdx1 and Set7/9 is independent of the 
target Lys residue being methylated.  
To ascertain the effects of the Pdx1 
mutations on DNA binding affinity, we next 
performed electrophoretic mobility shift assays 
(EMSAs).  Nuclear extracts from NIH3T3 cells 
transfected with Pdx1 proteins and Set7/9 were 
subjected to EMSA with 32P-labeled rat Ins1 
promoter E-A element (9, 36).  No apparent 
differences in the intensity of the Pdx1-specific 
complex were observed in the EMSAs (Fig. 4A).  
To quantitate more precisely whether subtle 
differences in binding affinity exist, we performed 
competition EMSAs using increasing 
concentrations of unlabeled E-A probe.  Binding 
competition curves were subsequently calculated 
and modeled based on single-phase exponential 
dissociation (Fig. 4B).  As shown in the Fig. 4B, 
none of the mutants exhibited dissociation 
constants that were different from the wild-type 
Pdx1 protein.  Taken together, the data in Figs. 3 
and 4 suggest that the transcriptional augmentation 
by Set7/9 that is enabled by methylation at K131 
likely involves transcriptional events that occur 
post binding to DNA, such as through the 
activation of the RNA polymerase II complex at 
the promoter (11). 
 
Residue K131 of Pdx1 is methylated in cells 
 We next asked if Pdx1 residue K131 is 
methylated by Set7/9 in cells.  To assess 
methylation in cells, we generated a peptide-based 
polyclonal antibody against methylated K131 of 
Pdx1.  Three different peptides (two methylated 
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and one unmethylated at Lys residues) 
corresponding to the Pdx1 sequence containing 
K131 were subjected to dot blots using varying 
dilutions of the antibody.  As shown in Fig. 5A, 
the antibody exhibited specificity for the Lys-
methylated peptides (Fig. 5A).  Corresponding 
specificity of the antibody for methylated full-
length Pdx1 was observed using recombinant Pdx1 
proteins methylated by Set7/9 in vitro (Fig. 5B): as 
expected, almost complete loss of 
immunoreactivity was observed with the K131R 
mutation.  However, some cross reactivity of the 
antibody was observed with methylated K123, 
since the K123R mutation showed a slight 
reduction in immunoreactivity (Fig. 5B).  These 
data confirm that K131 is a site for methylation by 
Set7/9 in vitro.  This antibody was then used to 
assess the methylation of Pdx1 proteins 
immunoprecipitated from cells.  Wild-type and 
mutant Pdx1 constructs containing an N-terminal 
hemagglutinin (HA) tag were transfected along 
with Set7/9 into HEK293 cells, which contain no 
endogenous Pdx1.  Pdx1 proteins were 
immunoprecipitated using an anti-HA antibody, 
then subjected to immunoblotting using the anti-
Pdx1(K131-Me) antibody.  As shown in Fig. 5C 
(lane 2), wild-type Pdx1 was methylated in cells, 
and the K131R and K123R/K131R double mutants 
showed clear reduction in methylation.  A slight 
reduction in the K123R mutant is consistent with 
cross-reactivity of the antibody for methylated 
K123.  Taken together, these data suggest that 
K131 (and possibly K123) are methylated in cell 
lines. 
 To determine if K131 is endogenously 
methylated in β cells, we immunoprecipitated 
methylated-Lys proteins from INS-1(832/13) 
insulinoma cells, then subjected the 
immunoprecipitate to immunoblotting using an 
anti-Pdx1 antibody.  Initial experiments from INS-
1 cells revealed no recovery of methylated Pdx1, 
raising the concern that β cells may contain 
demethylases that diminish the ability to detect 
Pdx1 methylation.  To circumvent this possibility, 
we pretreated INS-1 cells with the Lys 
demethylase inhibitor BP-107-7 (Fig. 5D, top 
panel).  INS-1 cells pretreated with 10 µM BP-
107-7 overnight were subjected to 
immunoprecipitation using anti-Pdx1 antibody and 
the resulting immunoprecipitate was 
immunoblotted with anti-methylated Lys antibody.  
As shown in Fig. 5D (lower panel), whereas INS-1 
cells treated with vehicle showed no recovery of 
methylated Pdx1, cells treated with BP-107-7 
showed a clear signal for Pdx1.  These data 
suggest that Pdx1 is endogenously methylated and 
demethylated in β cells.  To verify methylation at 
residue K131 in β cell lines, TAP-tagged Pdx1 
was overexpressed in MIN6 β cells using 
adenoviral gene transfer. The tagged Pdx1 protein 
was then purified from MIN6 β cells and analyzed 
by LC/MS/MS. Pdx1 was found to be both di- or 
tri-methylated at residue K131 (Fig. 2C shows 
data for the tri-methylated protein).  Collectively, 
these data suggest that K131 is a target of 
methylation in cells. 
 
Set7/9 is required for the maintenance of normal β 
cell function and glucose homeostasis in vivo 
In prior studies, our group showed that 
transient knockdown of Set7/9 in islet β cells 
results in a reduction in several gene targets of 
Pdx1 (26), yet the link between Set7/9 and β cell 
function in vivo has not been explored.  To 
address this link more directly, we generated mice 
in which Cre recombinase recognition (Loxp) sites 
flanked exon 2 of the gene encoding Set7/9 
(Setd7), such that conditional excision of the exon 
by Cre recombinase would result in a frame-shift 
and premature termination of the mRNA (Fig. 
6A). This strategy ensures deletion of both the 
putative Pdx-1 interaction domain (at the N-
terminus) and the methyltransferase domain (the 
SET domain) at the C-terminus.  Setd7Loxp/+ mice 
were crossed to mice that express the Cre 
transgene exclusively in islet β cells when treated 
with tamoxifen (MIP1-CreERT, ref. (21)).  
Setd7Loxp/Loxp;MIP1-CreERT mice and littermate 
controls (Setd7+/+;MIP1-CreERT and Setd7Loxp/Loxp) 
were treated with 5 daily doses of tamoxifen at 8 
weeks of age to generate β cell-specific Set7/9 
knockout mice (Set∆β) and controls, respectively.  
At 12 weeks of age (~3 weeks after conclusion of 
tamoxifen treatment), islets isolated from Set∆β 
mice showed a clear reduction in Set7/9 levels by 
immunoblot (Fig. 6B). 
Set∆β mice displayed impaired glucose 
tolerance following an intraperitoneal glucose 
challenge (Fig. 6C). To test the possibility that 
impaired glucose tolerance was caused by β cell 
dysfunction, we isolated islets from Set∆β mice and 
controls and performed glucose stimulated insulin 
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secretion studies in vitro.  As shown in Fig. 6D, 
islets from Set∆β mice displayed diminished 
glucose-stimulated insulin secretion compared to 
islets from controls, even when corrected for islet 
insulin content.  These data suggest a defect in 
insulin secretory mechanisms, and is reminiscent 
of defects seen in Pdx1-deficient islets (37, 38).  
Gene expression analysis of isolated islets 
revealed reductions in the mRNA levels of key 
Pdx1-regulated genes, including MafA, Slc2a2, 
Gck and Pdx1 itself in Set∆β islets compared to 
controls (Fig. 6E). The pre-mRNA and mRNAs 
encoding preproinsulin showed no change and a 
~2-fold increase, respectively, in Set∆β islets 
compared to controls, suggesting that the response 
of this gene may either be delayed compared to the 
other Pdx1 targets, or that it exhibits more 
complex regulation in the absence of Set7/9.  
Taken together, the data from Set∆β mice suggest a 
role for Set7/9 in the maintenance of key Pdx1 
target genes and overall glucose homeostasis in 
vivo, and parallels the phenotype seen with 
reductions in Pdx1 itself. 
 
DISCUSSION  
Pdx1 is required for both the development 
and function of islet β cells and, as such, the 
mechanism underlying its regulation of 
transcription has been the subject of numerous 
studies. Nevertheless, the full extent of the 
mechanisms governing Pdx1 action remains to be 
elucidated.  Set7/9 is a Lys methyltransferase that 
has been shown to interact with Pdx1 and augment 
Pdx1 action at several target genes (26).  In this 
study, we provide data suggesting that Set7/9-
mediated methylation of Pdx1 augments Pdx1 
transcriptional activity.  Although other studies 
have shown that Pdx1 can be regulated by 
phosphorylation (39–43), O-GlcNAcylation (44), 
and sumoylation (45), ours is the first study that 
shows that Pdx1 can be methylated.  Moreover, we 
show the close linkage between Pdx1 and Set7/9 
in vivo, where the loss of Set7/9 in β cells closely 
parallels the phenotype seen with the reduction in 
Pdx1 levels. 
In recent years, the number of identified 
non-histone targets of Set7/9 methylation has been 
increasing. Depending upon the protein, Lys 
methylation appears to affect a variety of functions 
at the transcriptional level, including protein-
protein interactions, protein stability, and DNA 
binding affinity (17, 35).  Notable proteins that are 
substrates of Set7/9 Lys methylation include p53 
(12), estrogen receptor-α (14), nuclear factor κB 
(13, 15, 46), and TATA box binding protein-
associated factor 10 (47), among others.  In this 
study, we show evidence that Pdx1 is methylated 
at Lys residues in vitro and in β cells.  An 
important finding in vitro was that recombinant 
Pdx1 was methylated by Set7/9, but occurred only 
in the context of the full length protein.  This 
requirement for context-dependent methylation 
seemingly differs from those reported in the 
literature, where Set7/9 has been shown to 
methylate Lys residues of specific small peptides, 
whose sequences could be subsequently used to 
predict the corresponding full-length protein 
targets (34, 48).  To our knowledge, none of the 
small peptide sequences presented in those studies 
correspond to sequences in Pdx1.  As such, our 
studies emphasize that targets of Set7/9 and 
possibly other SET domain-containing 
methyltransferases may not be predictable based 
on peptide sequence specificity. More detailed 
structural studies will be necessary to identify how 
specific secondary and tertiary structural folds of 
Pdx1 allow for its methylation by Set7/9. 
Our mass spectrometric and mutational 
analyses in vitro demonstrate that Pdx1 is 
methylated at two Lys residues in the N terminal 
transactivation domain, K123 and K131, with 
K123 being the apparent preferential target for 
Set7/9 in vitro.  Interestingly, K131 seems to be 
the more relevant target of methylation when Pdx1 
is expressed in cells, and suggests K131 
methylation has greater functional consequences 
in the context of the cellular milieu. Our finding 
that Pdx1 methylation becomes more apparent 
when cells are treated with Lys demethylase 
inhibitors suggests also that methylation may be 
transient in cells, or perhaps regulated depending 
upon the target gene or functions of Pdx1.  In this 
regard, there are several reports that show that 
proteins methylated by Set7/9 are reciprocally 
regulated by the demethylase LSD-1 (49–52).  
Whereas methylation of Pdx1 by Set7/9 in 
vitro resulted in mono-methylation of K131 (and 
K123), our overexpression studies in β cells 
showed that K131 was di- and tri-methylated.  
This observation raises an important issue that has 
been discussed in the literature on the 
stoichiometry of Lys methylation by Set7/9.  Some 
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studies have suggested that Set7/9 functions as a 
di-methyltransferase (53), whereas others suggest 
it is exclusively a mono-methyltransferase (54).  
These seemingly contradictory observations could 
be explained by at least three possibilities:  (a) 
mono- vs. di-methylation could be sequence-
dependent.  In this respect, studies have shown 
that some peptide sequences are di-methylated by 
Set7/9 in vitro, whereas other peptide sequences 
are mono-methylated (34); (b) in β cells, 
interacting proteins may alter the nature of Lys 
methylation by Set7/9.  For example, the 
methyltransferase G9a exhibits differing 
stoichiometries of methylation in vivo depending 
the presence of interacting proteins (55); and (c) 
Set7/9 may be the first in a cascade of different 
methyltransferases that achieves di- and tri-
methylation of Pdx1 residue K131 in cells.   
Set7/9 has been previously shown to 
augment Pdx1 transcriptional activity in reporter 
gene assays (11).  Here, we observed that Pdx1 
residue K131 is necessary for this augmentation, 
since mutation of this residue to Arg (K131R) 
abrogates transcriptional augmentation.  Although 
the transcriptional augmentation by Set7/9 is only 
about 40%, the effects of such reductions may 
have biologically significant consequences in the 
longer term.  We next probed possible reasons for 
how the K131R mutation abrogates transcriptional 
augmentation by Set7/9.  We found that mutation 
did not hamper Pdx1-Set7/9 interactions (as 
determined by co-immunoprecipitation 
experiments) or DNA binding affinity (based on 
EMSA analysis).  However, It remains possible 
that binding to target genes in the nucleus may be 
subtly altered by the mutations. Nevertheless, 
based on our data, we believe that Pdx1 
methylation at K131 may affect the interactions of 
the Pdx1 transcriptional complex with basal 
transcriptional machinery.  In support of this 
possibility, we previously showed that Pdx1-
Set7/9 interaction was associated with activation 
of RNA polymerase II (11, 56).  
Finally, to interrogate the relationship 
between Set7/9 and Pdx1 target genes in β cells in 
vivo, we generated mice with tamoxifen-inducible 
β cell-specific deletion of Set7/9 (Set∆β).  Similar 
to mice with haploinsufficiency of Pdx1, Set∆β 
mice exhibited glucose intolerance and β cell 
dysfunction (37).  Several Pdx1 target genes were 
reduced in Set∆β mice, consistent with the close 
functional linkage between Set7/9 and Pdx1. Our 
results are similar to those we previously 
published using RNA interference to deplete 
Set7/9 acutely in islets (26).  Although these 
studies do not definitively prove a link between 
Set7/9 and methylated Pdx1 (since the loss of 
Set7/9 may have consequences on broader gene 
expression), these results do suggest that Pdx1 
may be dependent upon the action of Set7/9 for 
full activity in vivo.   
Taken together, our data suggest a 
previously unappreciated posttranslational 
modification of Pdx1 that appears to affect its 
transcriptional activity.  Our studies show the 
methylation of Pdx1 residue K131, the 
requirement of K131 for the augmentation of gene 
transcription in reporter assays, the occurrence of 
K131 methylation in β cell lines, and the 
requirement for Set7/9 in the maintenance of at 
least a subset of Pdx1 target genes in vivo.  Some 
limitations and alternative interpretations of our 
study must be acknowledged.  Most notably, it 
remains possible that the effects observed in our 
reporter assays or in Set∆β mice are not directly 
related to methylation of Pdx1 per se, but rather to 
a separate requirement for residue K131 or Set7/9, 
respectively, on gene transcription.  Gene knock-in 
studies in mice (using the K131R mutation of 
Pdx1) may be more appropriate to address this 
issue in the future.  Also, our studies do not 
exclude the possibility in vivo that Set7/9 is 
directly necessary for the maintenance of 
chromatin structure (histone methylation) at 
several of the Pdx1 target genes examined, or that 
it acts in concert with β cell transcription factors 
other than Pdx1.  Nevertheless, our studies provide 
a framework for understanding better the nuances 
of transcriptional regulation by Pdx1.  We propose 
a model in which Pdx1 methylation at residue 
K131 via Set7/9 is required for the maintenance of 
transcription at selected target genes.  Whereas 
this model does not exclude the possibility (as 
purported in prior studies) that histone methylation 
by Set7/9 also contributes to transcriptional 
activity, it emphasizes that transcription factor-
cofactor interactions can achieve functional 
transcriptional complexes in many ways.  
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FIGURE LEGENDS 
 
Figure 1. Pdx1 methylation by Set7/9 in vitro. (A) Methylation assay in vitro using recombinant Set7/9, 
3H-AdoMet, and increasing concentrations of Pdx1 protein was performed, then reactions were subjected 
to polyacrylamide gel electrophoresis.  Upper panels show fluorography for 3H and lower panels show 
corresponding Coomassie staining of the same gel; (B) Methylation assay in vitro using recombinant 
Set7/9, 3H-AdoMet, and full-length or truncated Pdx1 proteins was performed, followed by 
polyacrylamide gel electrophoresis.  Schematic representation of truncated mutants of Pdx1 is shown in 
the right, and corresponding 3H fluorography and Coomassie stains are shown on the left; (C) Methylation 
assays in vitro using wild-type (WT) and mutated Pdx1 proteins was performed, with corresponding 
quantitation of methylated Pdx1 protein intensities (normalized to total Pdx1 protein by Coomassie 
staining).  All images shown are representative of at least N=3 experiments. *p<0.05 compared to wild-
type Pdx1. 
 
Figure 2.  MS/MS spectra of Pdx1 in vitro and in MIN6 cells. (A) Tandem mass spectrum of the 
peptide GQLPFPWMK showing modification of K123 with mono-methylation (+14 dalton) following 
treatment with recombinant Set7/9 in vitro. The SEQUEST XCorr for this +2 peptide is 1.83 with a ppm 
of -1.65; (B) Tandem mass spectrum of the +3 peptide AHAWKGQWAGGAYAAEPEENKR showing 
mono-methylation (+14 dalton) of K131 in Pdx1 following treatment with recombinant Set7/9 in vitro. 
The SEQUEST XCorr for this peptide is 6.19 with a ppm of 0.34; (C) Representative MS/MS spectrum 
from an LTQ ion trap for the +2 peptide AHAWKGQWAGGAYAAEPEENKR showing tri-methylation 
at K131 in Pdx1 in transduced MIN6 β cells.  The SEQUEST XCorr for this peptide is 2.24 with a ppm of 
19.25.  
 
Figure 3. Transcription augmentation by Set7/9 is dependent upon Pdx1 residue K131.  NIH3T3 
were transiently co-transfected with Set7/9, wild-type (WT) and mutant Pdx1 proteins, and either Pdx1 
reporter plasmid or Gal4 reporter plasmid. Cells were harvested 48 hours later and whole cell extracts 
were used to assay luciferase activity. (A) Luciferase activities (relative to control transfections without 
Pdx1) with the Pdx1 reporter plasmid, which contains tandem elements of the Ins E2/A3/A4 element 
(schematic diagram of reporter shown at the top). N=3 transfections in triplicate, *P<0.05 for the 
comparisons shown;  (B) Luciferase activities (relative to control transfections without Pdx1) with the 
Gal4 reporter plasmid, which contains tandem elements of the yeast Gal4 DNA binding domain 
(schematic diagram of reporter shown at the top).  N=3 transfections in triplicate; (C) Immunoblots (for 
the indicated proteins) from whole cell extract from transfected cells. Results are representative of N=3 
transfections; (D) NIH3T3 cells were transfected with FLAG-Set7/9 and the indicated Pdx1 proteins, then 
nuclear extracts were subjected to immunoprecipitation using FLAG antibody, the immunoblotted using 
Pdx1 antibody.  Results are representative of N=2 experiments.  
 
Figure 4. Point mutations do not affect DNA binding by Pdx1. (A) NIH3T3 cells were co-transfected 
with the wild-type (WT) or mutant Pdx1 proteins, with or without cotransfection of Set7/9. Nuclear 
extracts from transfected cells were harvested and subjected to EMSA using 32P-labeled E-A DNA 
fragment containing a Pdx1 binding site derived from the Ins E2/A3/A4.  The positions of the Pdx1-
containing complex and the unbound, free probe (FP) are indicated by the arrows.  The bottom panel 
shows immunoblots for Pdx1 and GAPDH from the same nuclear extracts used for the EMSA; (B) 
Quantitation and modeling of EMSA reactions (as in A), with increasing concentrations of unlabeled E-A 
probe.  For each Pdx1 mutant, the control condition is the fraction of total probe bound in the absence of 
competitor.  The ordinate represents probe binding (at the given competitor concentration) as a percent of 
the control condition. The apparent dissociation constants of the WT and mutant proteins is shown in the 
inset, with no statistical differences seen.  Data shown are from N=3 EMSA experiments.  
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Figure 5. Residue K131 of Pdx1 is methylated in cells. (A) Dot blot analysis using two dilutions of anti-
Pdx1(K131-Me) antibodies and methylated and unmethylated peptides corresponding to the N-terminus 
of Pdx1 containing residue K131; (B) Representative immunoblots (top panels) using anti-Pdx1(K131-
Me) antibody or anti-Pdx1 antibody on recombinant Pdx1 proteins methylated by Set7/9 in vitro. 
Quantitation of immunoblots (N=3) is shown in the bottom panel bar graph. *P<0.05 compared to Pdx1 
alone; (C) HEK293 cells were transfected with Set7/9 and wild-type (WT) or mutant HA-tagged Pdx1 
proteins, then whole-cell extracted were immunoprecipitated using anti-HA antibody, followed by 
immunoblot analysis using anti-Pdx1 and anti-Pdx1(K131-Me) antibodies (top panels). Quantitation of 
methylated Pdx1 (relative to total immunoprecipitated Pdx1) (N=3) is shown in the bottom panel bar 
graph. *P<0.05 compared to WT Pdx1; (D) Top: chemical structure of the Lys demethylase inhibitor BP-
107-7 (top). Bottom: INS-1 832/13 β cells were treated with vehicle or BP-107-7 (10 µM) overnight, then 
nuclear extracts were immunoprecipitated using anti-methyl Lys antibody followed by immunoblot using 
anti-Pdx1 antibody.  
 
Figure 6. β cell-specific deletion of Set7/9 in mice. (A) Schematic representation of WT and mutant 
alleles present in control and mutant mice, respectively, showing positions of the exons (numbered) and 
the Loxp sites; (B) Immunoblot analysis of whole cell lysates of islets isolated from Setd7+/+;MIP1-CreERT 
(MIP1-Cre), Setd7Loxp/Loxp (Lox/Lox), and MIP1-CreERT;Setd7Loxp/Loxp (SetΔβ) mice for Set7/9 (upper panel) 
and GAPDH (lower panel); (C) Results of intraperitoneal GTT on MIP1-Cre (N=12), Lox/Lox (N=9) and 
SetΔβ (N=12) mice (left panel), with corresponding area under the curve (AUC) analysis (right panel). 
*P<0.05 compared to either MIP1-Cre or Lox/Lox; (D) Results of glucose-stimulated insulin release 
assays from islets isolated from MIP1-Cre, Lox/Lox, and Set∆β mice (left panel), and corresponding ratio 
of insulin secreted at high glucose relative to low glucose is shown in the right panel.  N=3, *P<0.05 
compared to either MIP1-Cre or Lox/Lox; (E) Results of real-time RT-PCR for the indicated genes from 
islets isolated from control (MIP1-Cre and Lox/Lox) vs. Set∆β mice.  Data are normalized to Actb mRNA 
levels, N=4 independent islet isolations, *P<0.05 compared to control.  
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